Overview

Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant
Phase:
PHASE1
Details
Lead Sponsor:
Cairo University
Treatments:
Enoxaparin
N(4)-oleylcytosine arabinoside